Home » U.S. FDA Accepts Epanova NDA
U.S. FDA Accepts Epanova NDA
The FDA has accepted AstraZeneca’s NDA for Epanova, a drug that treats patients with extremely high triglyceride levels.
The Pharma Letter
The Pharma Letter
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May